Hvsen

300871.SZ

Tags: CN Healthcare Biotechnology

Hvsen Biotechnology Co., Ltd. Price (300871.SZ)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

165,982,423

(0.333)%

Market Cap of Hvsen (300871.SZ)

Market cap:

As of , 300871.SZ has a market cap of . This makes 300871.SZ the 3652th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin raw materials, various tylvalosin preparations, florfenicol preparations, and other macrolides products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. is based in Wuhan, China. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $7.6-16.49
Market Cap 2.21B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Kaijie Yang
IPO Date: August, 24, 2020
Country: CN
Currency: CNY
Headquaters: No Data
Employees: 1068

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: